Artelo Biosciences gets Japan notice of allowance for ART27.13 formulation patents
Artelo Biosciences (ARTL) secures a notice of allowance in Japan covering patent claims for the intended commercial formulation of ART27.13.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.